Peter Vanderbruggen

Directeur Général chez

Leeward Ventures Management SA

Health Technology

Finance

Process Industries

Profil

Peter Vanderbruggen is a Director of RHEI Pharmaceuticals, Inc. He is Founder and Managing Director of Leeward Ventures SICAR.

Sociétés	Poste	Début
RHEI Pharmaceuticals, Inc. RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acquires, licenses, develops and commercializes therapies	Directeur/Membre du Conseil	-
Leeward Ventures Management SA Leeward Ventures Management SA Investment ManagersFinance Leeward Ventures Management SA invests in private and small public companies located in Europe, the US and Asia. Its investment strategy focuses across a broad range of sectors such as pharmaceuticals, process industries, information technology services and internet software/services. It also makes opportunistic investments in real estate sector. It makes minority equity investments for early and later stage venture capital backed companies and takes majority stake in undervalued companies. It also provides expansion capital, hybrid financing and mezzanine and convertible debt obligations, across a wide spectrum of startup and growth financings, management buyouts and recapitalizations. It provides €1M - €5M per transaction.	Directeur Général	30/05/2011
BeoCare Group, Inc. BeoCare Group, Inc. TextilesProcess Industries Manufactures knitted medical textiles	Président	-

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Entreprise privées	3
RHEI Pharmaceuticals, Inc. RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acquires, licenses, develops and commercializes therapies	Health Technology
Leeward Ventures Management SA Leeward Ventures Management SA Investment ManagersFinance Leeward Ventures Management SA invests in private and small public companies located in Europe, the US and Asia. Its investment strategy focuses across a broad range of sectors such as pharmaceuticals, process industries, information technology services and internet software/services. It also makes opportunistic investments in real estate sector. It makes minority equity investments for early and later stage venture capital backed companies and takes majority stake in undervalued companies. It also provides expansion capital, hybrid financing and mezzanine and convertible debt obligations, across a wide spectrum of startup and growth financings, management buyouts and recapitalizations. It provides €1M - €5M per transaction.	Finance
BeoCare Group, Inc. BeoCare Group, Inc. TextilesProcess Industries Manufactures knitted medical textiles	Process Industries